GSK Reports U.S. Food and Drug Administration Grants Breakthrough Therapy Designation and Priority Review Acceptance for Bepirovirsen in Chronic Hepatitis B as Potential First-in-Class Treatment Ionis Pharmaceuticals and its partner GSK have reached a significant regulatory milestone in the development…
Janux Therapeutics Halts Development of JANX008 Program Janux Therapeutics, Inc. has announced its decision to discontinue further clinical development of JANX008, an investigational EGFR-targeted Tumor Activated T Cell Engager (TRACTr) therapy, following completion of early-stage clinical evaluation and an internal…
Supported by Over $1 Billion in Investment, PCI Pharma Services Unveils Major Expansion of U.S. Sterile Fill-Finish and Drug–Device Combination Capabilities PCI Pharma Services has unveiled an extensive series of infrastructure investments aimed at significantly strengthening its sterile fill-finish capabilities…
vVARDIS Secures Strategic Investment from Apollo, Reaching Unicorn Valuation vVARDIS Holding AG, a rapidly expanding dental medtech innovator focused on transforming the way tooth decay is treated, has announced a strategic minority investment from funds managed by Apollo Global Management.…
Adagio Medical Reports Successful Pivotal Outcomes for vCLAS® Ventricular Ablation System Adagio Medical Holdings, Inc. has reported compelling six-month clinical outcomes from its pivotal FULCRUM-VT Investigational Device Exemption (IDE) trial, marking a significant milestone in the advancement of catheter ablation…
Dental Care Alliance Unveils Strategic Transaction to Bolster Financial Stability and Drive Long-Term Growth Dental Care Alliance (DCA), one of the largest dental support organizations in the United States, has announced a major financial restructuring agreement with its existing lender…
HealthPartners Highlights Ongoing Progress, Key Priorities, and Future Actions to Advance Simpler, More Affordable Health Care Amid a persistent rise in both medical and pharmacy costs, HealthPartners is stepping up its efforts to make health care more accessible, understandable and…
Bausch + Lomb Publishes Review on B Vitamins and Their Role in Reducing Risk and Progression of Age-Related Macular Degeneration Bausch + Lomb Corporation has announced the publication of a major scientific narrative review in the peer-reviewed journal Ophthalmology and…
AbbVie Chooses North Carolina as Site for $1.4 Billion Advanced Manufacturing Facility AbbVie has unveiled an ambitious new chapter in its long-term growth strategy with the announcement of a $1.4 billion investment to establish a cutting-edge pharmaceutical manufacturing campus in…
Kennel Connection Forms Exclusive Partnership with Petwealth to Deliver Clinical-Grade Pet Health Screening Across Pet Care Facilities Nationwide Kennel Connection, a leading provider of pet care facility management software and part of the 100GROUP portfolio, has announced a significant advancement…
Flatiron Health Highlights 18 Accepted Studies Leveraging Real-World Data for Presentation at ISPOR 2026 Flatiron Health has announced a significant presence at the ISPOR Annual Meeting 2026, taking place from May 17 to May 20, 2026, in Philadelphia. The company’s…
Vyome Showcases Transformative Phase 2 Clinical Results for VT-1953 at AACR 2026 Vyome Holdings, Inc. (Nasdaq: HIND), a clinical-stage biotechnology company focused on developing innovative therapies for underserved conditions, has unveiled comprehensive Phase 2 investigator-initiated study results along with supporting…